CVS trends higher after raising outlook Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- CVS Health (CVS) up 1% after raising its FY21 adjusted EPS view
- Illumina (ILMN) up 5% after giving guidance last night in conjunction with a conference presentation
- Charles River (CRL) up 4% after providing FY22 guidance following its CFO transition announcement
- Bluebird Bio (BLUE) up 6% after reporting preliminary unaudited cash figures and providing an update on program milestones
- American Resources (AREC) up 4% after announcing partnership in which Heritage Group will receive a 7.5% ownership stake of American Rare Earth with American Resources retaining ownership of 92.5% of the equity interest
UP AFTER EARNINGS -
- TSR (TSRI) up 36%
- Accolade (ACCD) up 12%
DOWN AFTER EARNINGS -
LOWER -
- IBM (IBM) down 3% after UBS analyst David Vogt downgraded shares to Sell from Neutral with a price target of $124, down from $136
- Rivian Automotive (RIVN) down 4% after Wall Street Journal reported the company's chief operating officer, Rod Copes, had retired from the company in December
- Alcoa (AA) down 1% after Deutsche Bank analyst Sathish Kasinathan downgraded the stock to Hold
- TechnipFMC (FTI) down 6% after proceeding with the voluntary delisting of its shares from Euronext Paris and announcing the sale of part of its stake in Technip Energies
Symbols:
CRL BLUE AREC ACI TSRI ACCD IBM RIVN AA FTI CVS ILMN Keywords: Fly Intel, Wall Street, Top Stories, Stocks